Mathias Svahn

Mathias Svahn is an experienced professional in the biotechnology and medical sectors, currently serving as Chairman and CEO of Cellaviva, as well as CEO of NextCell Pharma AB, and a member of the supervisory boards for both Cellaviva and FamiCordTx. Svahn's previous roles include Senior Researcher at Karolinska Institutet and Country Medical Manager at Roche, focusing on oncology and pipeline substances. Svahn holds multiple doctoral degrees in Molecular Cell Biology and Gene Therapy from Karolinska Institutet, along with a Master of Science in Molecular Biotechnology from Uppsala University and a Master's in Economics and Entrepreneurship from the Stockholm School of Economics. With extensive experience in clinical studies, project management, and research, Svahn has contributed significantly to efforts in stroke care and cellular therapies.